BlackRock Fund Advisors - DIPEXIUM PHARMACEUTICALS INC ownership

DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 29 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of DIPEXIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$26,000
-88.6%
16,415
+4.3%
0.00%
Q3 2016$228,000
+47.1%
15,733
+0.4%
0.00%
Q2 2016$155,000
+24.0%
15,674
+19.6%
0.00%
Q1 2016$125,000
-19.9%
13,106
-6.1%
0.00%
Q4 2015$156,00013,9580.00%
Other shareholders
DIPEXIUM PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Lone Star Value Management LLC 229,841$2,574,0004.76%
KINGDON CAPITAL MANAGEMENT, L.L.C. 975,099$10,921,0000.53%
Timpani Capital Management LLC 95,647$1,071,0000.44%
Broadfin Capital, LLC 465,978$5,219,0000.32%
1492 Capital Management LLC 34,819$390,0000.28%
Tourbillon Capital Partners, L.P. 791,856$8,869,0000.20%
Opus Point Partners Management, LLC 25,000$280,0000.18%
683 Capital Management, LLC 70,000$784,0000.11%
ARDSLEY ADVISORY PARTNERS LP 50,000$560,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 14,198$159,0000.07%
View complete list of DIPEXIUM PHARMACEUTICALS INC shareholders